Filing Flows › Glaukos (GKOS) › Glaucoma revenue
Glaukos (GKOS) Glaucoma revenue by quarter
Glaukos' Glaucoma revenue was $152M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 7 quarters it ranged from $88.1M (Q1 2025) to $155M (Q2 2026).
| Quarter | Glaucoma revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $152M | -2% | +38% |
| Q2 2026 | $155M | +20% | +50% |
| Q1 2026 | $129M | +8% | +47% |
| Q4 2025 | $119M | +8% | — |
| Q3 2025 | $110M | +6% | — |
| Q2 2025 | $104M | +17% | — |
| Q1 2025 | $88.1M | — | — |
Q3 2026 at a glance
Glaukos, Q3 2026: revenue $211M (+58% year over year), operating margin 0.4%, net earnings $2.0M, operating cash flow $38.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Glaukos' Glaucoma revenue?
Glaukos' Glaucoma revenue was $152M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Glaukos' Glaucoma revenue changed?
Over the last 7 quarters it ranged from $88.1M (Q1 2025) to $155M (Q2 2026).